BostonGene and Collaborators Honored with GRASP Advocate Choice Award at the 2024 ASCO Annual Meeting
BostonGene , a leading provider of AI-driven molecular and immune profiling solutions, today announced the presentation of its poster at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting has received the GRASP Advocate Choice Award.
- BostonGene , a leading provider of AI-driven molecular and immune profiling solutions, today announced the presentation of its poster at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting has received the GRASP Advocate Choice Award.
- Founded in 2019 by two breast cancer survivors and advocates, GRASP aims to break down silos and foster connections within the cancer community.
- The 2024 GRASP event will be held in conjunction with the ASCO Annual Meeting on June 12-13, 2024.
- "Our collaborative efforts in TME profiling are vital in unraveling the complexities of ILC and tailoring personalized treatments for patients."